Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
06.04. | Wipro Limited: Wipro ernennt Srini Pallia zum CEO und Geschäftsführer | 473 | Business Wire | Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), ein führendes Technologie- und Beratungsunternehmen, gab heute die Ernennung von Srini Pallia zum Chief Executive Officer und Geschäftsführer des... ► Artikel lesen | |
06.04. | Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society | 611 | Business Wire | KarXT demonstrated a favorable long-term metabolic profile where most patients experienced stability or improvements on metabolic parameters over 52 weeks of treatment A majority of patients (65%)... ► Artikel lesen | |
06.04. | Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society | 647 | Business Wire | Long-term treatment with KarXT was associated with continued improvements in symptoms of schizophrenia across all efficacy measures at 52 weeks More than 75% of participants achieved 30% improvement... ► Artikel lesen | |
06.04. | Teva Pharmaceutical Industries Limited: New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY (risperidone) Extended-Release Injectable Suspension at SIRS 2024 | 782 | Business Wire | PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable (LAI) formulation of risperidone microspheres (R064766)... ► Artikel lesen | |
06.04. | Daiichi Sankyo: ENHERTU Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors | 1.669 | Business Wire | Based on three phase 2 trials of Daiichi Sankyo and AstraZeneca's ENHERTU that showed clinically meaningful responses across a broad range of tumors
ENHERTU now has five approved indications... ► Artikel lesen | |
06.04. | SSR Mining Inc.: SSR Mining Provides Update on Çöpler Incident | 618 | Business Wire | SSR Mining Inc. (Nasdaq/TSX: SSRM; ASX: SSR) ("SSR Mining" or the "Company") provides an update on the ongoing recovery efforts at the Çöpler mine in Türkiye.
Since the February 13, 2024 incident... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 3.255 |
SUPER MICRO COMPUTER | 2.397 |
BYD | 2.028 |
BAYER | 1.926 |
NVIDIA | 1.448 |
NEL | 1.288 |
DEUTSCHE BANK | 1.215 |
TUI | 1.198 |
APPLE | 1.187 |
TESLA | 1.124 |
AMAZON | 948 |
MERCEDES-BENZ | 868 |
VOLKSWAGEN | 812 |
COMMERZBANK | 753 |
NOVO NORDISK | 748 |
PLUG POWER | 746 |
PFIZER | 719 |
AIXTRON SE | 717 |
HUGO BOSS | 648 |
PAYPAL | 615 |
CANOPY GROWTH | 608 |
RHEINMETALL | 595 |
AMD | 583 |
DEUTSCHE LUFTHANSA | 583 |
BIONTECH | 582 |